Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 57 for your search:
Drug:  epoetin alfa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0011004, ORTHO-PR-00-27-012, ORTHO-PR-01-27-003, NCI-G01-2002, NCT00022386

2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003541, NCT00216541

3.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003460, EPOSUR4001, NCT00264095

4.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR002455, EPOCAN4015, NCT00264108

5.

Phase: Phase IV
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR005596, EPOCAN4018, NCT00398749

6.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLBH589BDE04, EudraCT 2009-010403-84, 2009-010403-84, NCT01034657

7.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RWJPRI-EPO-CA-480, NCI-V96-0978

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18-80
Sponsor: NCI
Protocol IDs: RPCI-DS-97-10, ORTHO-PR-96-27-004, NCI-G98-1394

9.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-97125, ORTHO-PR-96-27-031, RPCI-DS-97-38, NCI-G98-1436, NCT00003341

10.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066673, NCCTG-979253, NCI-P98-0133, 97-92-53, NCT00003600

11.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9903, CDR0000067599, RTOG-DEV-1008, NCT00004917

12.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0191, NCI-2012-02384, CAN-NCIC-CX4, CDR0000068641, U10CA027469, CX4, NCT00017004

13.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20010101, UCLA-0201098, NCI-G02-2112, AMGEN-200101101, NCT00046982, NCT00038064

14.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000288821, NCCTG-N02C2, NCT00058331

15.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000301881, ECOG-E1Z01, E1Z01, NCT00060398

16.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000333213, P30CA016042, UCLA-0306021, AMGEN-20030125, NCT00070382

17.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003223, NCT00210587

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 19 to 80
Sponsor: Other
Protocol IDs: OEGRO54, NCT00348738

19.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: Over 16
Sponsor: Other
Protocol IDs: BARTS-06/Q0605/93, ISRCTN11830961, EU-20731, 06/Q0605/93, NCT00482716

20.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0890, NCT00656448

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 60 and under
Sponsor: Other
Protocol IDs: MA21, CAN-NCIC-MA21, AMGEN-CAN-NCIC-MA21, NCCTG-CAN-NCIC-MA21, BMS-CAN-NCIC-MA21, JANSSEN-ORTHO-CAN-NCIC-MA21, PFIZER-CAN-NCIC-MA21, SWOG-CAN-NCIC-MA21, CDR0000068520, CALGB-CAN-NCIC-MA21, NCIC-MA21, NCT00014222

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069148, CCCWFU-62299, CCCWFU-BG01-193, NCI-P01-0200, NCT00028938

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065907, E1996, U10CA021115, ECOG-1996, NCT00003138

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR018367, EPOANE3021, 2010-022884-36, NCT01381809

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPMI-DS-9429, NCI-T94-0072D, T94-0072
1    
New Search